Albany College of Pharmacy and Health Sciences
Albany, New York, 12208, United States
NCT Number: NCT01035333
The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Albany, New York, 12208, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
60mg capsule three times a day for up to 6 months
Other names: Alli
Time frame: 6 months
Weight loss acheived during time on study up to 6 months.
Time frame: 6 months
Albany College of Pharmacy and Health Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05093634
Body Weight, Genetic Obesity
Phoenix, Arizona, United States
View Trial DetailsNCT06066528
Body Weight, Diabetes Mellitus
Anniston, Alabama, United States
View Trial DetailsNCT01828788
Body Weight, Bronchial Diseases
Clermont-Ferrand, France
View Trial DetailsNCT04114903
Body Weight, Cannabis Use
Boulder, Colorado, United States
View Trial Details